1. Home
  2. ONC vs NTR Comparison

ONC vs NTR Comparison

Compare ONC & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$268.53

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$62.47

Market Cap

34.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONC
NTR
Founded
2010
2017
Country
Switzerland
Canada
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
34.2B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ONC
NTR
Price
$268.53
$62.47
Analyst Decision
Strong Buy
Buy
Analyst Count
10
22
Target Price
$385.10
$75.45
AVG Volume (30 Days)
257.0K
2.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$723.76
$4.03
Revenue Next Year
$15.04
N/A
P/E Ratio
$614.06
$18.99
Revenue Growth
N/A
N/A
52 Week Low
$239.25
$53.03
52 Week High
$385.22
$85.36

Technical Indicators

Market Signals
Indicator
ONC
NTR
Relative Strength Index (RSI) 39.72 30.46
Support Level $253.95 $58.39
Resistance Level $323.73 $63.94
Average True Range (ATR) 7.22 1.57
MACD -0.37 -0.32
Stochastic Oscillator 44.16 2.01

Price Performance

Historical Comparison
ONC
NTR

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Share on Social Networks: